Gastrin-releasing peptide receptor overexpression has been demonstrated in many types of cancer (Cornelio et al., 2007), and we have recently shown widespread expression and a high content of GRPR in human glioma, the most common and lethal type of neurological cancer (Flores et al., 2010; Figure 4). This evidence concerns the gene GRPR and central nervous system cancer.